Products from Promensil®
![]() |
Promensil® MenopauseNPN 80015467 Dose: 1 tablet contains 40 mg AIE of standardized red clover isoflavones. Take 1 tablet daily (or 2 if symptoms are more severe) with the morning or evening meal, depending when symptoms are more severe, during the day or night. Trial: Most women will experience efficacy in 3 to 8 weeks. Recommended Use: May reduce severe and frequent hot flashes. Helps to reduce Bone Mineral Density losses with adequate intake of calcium and vitamin D in post menopausal women. May support cardiovascular health by improving arterial compliance. |
![]() |
Promensil® Menopause Double StrengthNPN 80016071 Dose: 1 tablet contains 80 mg AIE of standardized red clover isoflavones. Take 1 tablet daily with the morning or evening meal, depending when symptoms are more severe, during the day or night. Trial: Most women will experience efficacy in 3 to 8 weeks. Recommended Use: Helps reduce severe and frequent hot flashes. May reduce menopausal symptoms such as night sweats, sleeping disorders, nervousness, lack of concentration and vaginal dryness. Helps to reduce Bone Mineral Density losses with adequate intake of calcium and vitamin D in post menopausal women. May support cardiovascular health by improving arterial compliance. |
![]() |
Promensil® Vitality for After MenopauseNPN 80016069 Dose: 1 tablet contains 40 mg AIE of standardized red clover isoflavones, plus 500 mg of elemental calcium (from calcium carbonate) and 140 IU (3.5 µg) of vitamin D3 (from cholecalciferol). Take 1 tablet daily with a meal. Trial: Most women will experience efficacy in 3 to 8 weeks. Recommended Use: Helps to reduce Bone Mineral Density losses in post-menopausal women. Helps support cardiovascular health by improving arterial compliance. Vitamin D helps the body to better absorb calcium. Adequate calcium as part of a health diet prevents bone loss and osteoporosis. |
Cautions and Warnings
Promensil® is well tolerated in healthy women.
-
Not recommended for use in pregnant or
breastfeeding women, or for children under 15.
-
Ensure patient is up-to-date on mammograms
and gynaecological evaluations prior to use.
-
Do not use if patient has or had breast cancer,
or has a predisposition to breast cancer as indicated
by an abnormal mammogram and/or biopsy.
Patients using Promensil® are recommended
to consult with their healthcare professional if:
-
they have a bleeding disorder or
are taking blood thinning medication
-
symptoms worsen
-
they are taking hormone replacement therapy,
including thyroid hormone replacement therapy
-
they have a history of hormonal or gynaecological disease
including ovarian cancer, endometriosis, and/or uterine fibroids.
-
they have a liver disorder or develop liver-related symptoms
(e.g. abdominal pain, jaundice, dark urine)
-
they use Promensil® beyond 1 year
-
they experience breast pain, discomfort and/or tenderness, or they experience a recurrence of menstruation and/or uterine spotting
Contra-Indications
Should not be used in patients who are hypersensitive to the ingredients.




